NeuroSense Therapeutics (NRSN) P/E (2021 - 2026)
NeuroSense Therapeutics (NRSN) P/E from Dec 31, 2021 to Jul 21, 2026. The TTM NeuroSense Therapeutics (NRSN) P/E is -2.05. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of NeuroSense Therapeutics (NRSN)
| Year | P/E | Change |
|---|---|---|
| 2026 | -2.05 | -8.97% |
| 2025 | -2.25 | -17.53% |
| 2024 | -2.73 | +209.65% |
| 2023 | -0.88 | -53.24% |
| 2022 | -1.89 | -50.41% |
| 2021 | -3.80 | N/A |
Comparison NeuroSense Therapeutics (NRSN) P/E with competitors
NeuroSense Therapeutics (NRSN) P/E is -2.05.